AIA Group Ltd Purchases 8,027 Shares of CME Group Inc. (NASDAQ:CME)

AIA Group Ltd grew its stake in CME Group Inc. (NASDAQ:CME) by 109.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 15,392 shares of the financial services provider’s stock after acquiring an additional 8,027 shares during the quarter. AIA Group Ltd’s holdings in CME Group were worth $3,314,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. B. Riley Wealth Advisors Inc. increased its position in CME Group by 1.3% during the fourth quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock valued at $782,000 after acquiring an additional 48 shares during the last quarter. Capital Advisors Ltd. LLC increased its position in CME Group by 4.3% during the first quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after acquiring an additional 48 shares during the last quarter. Lantz Financial LLC increased its position in CME Group by 1.1% during the first quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock valued at $982,000 after acquiring an additional 49 shares during the last quarter. Transcend Capital Advisors LLC increased its position in CME Group by 1.7% during the fourth quarter. Transcend Capital Advisors LLC now owns 2,995 shares of the financial services provider’s stock valued at $631,000 after acquiring an additional 50 shares during the last quarter. Finally, Greystone Financial Group LLC increased its position in CME Group by 1.6% during the fourth quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock valued at $691,000 after acquiring an additional 52 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, Director Charles P. Carey sold 3,000 shares of the business’s stock in a transaction dated Thursday, June 13th. The stock was sold at an average price of $195.44, for a total value of $586,320.00. Following the completion of the transaction, the director now owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction dated Thursday, June 13th. The stock was sold at an average price of $195.44, for a total value of $586,320.00. Following the completion of the transaction, the director now owns 7,163 shares in the company, valued at approximately $1,399,936.72. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Elizabeth A. Cook sold 1,000 shares of CME Group stock in a transaction dated Monday, May 20th. The shares were sold at an average price of $211.52, for a total value of $211,520.00. Following the completion of the transaction, the director now owns 18,241 shares of the company’s stock, valued at approximately $3,858,336.32. The disclosure for this sale can be found here. In the last 90 days, insiders sold 54,290 shares of company stock valued at $11,393,700. 0.30% of the stock is owned by company insiders.

CME Group Stock Down 1.2 %

Shares of NASDAQ:CME traded down $2.37 on Friday, reaching $193.43. The company had a trading volume of 3,124,714 shares, compared to its average volume of 1,969,101. CME Group Inc. has a 52-week low of $180.88 and a 52-week high of $223.80. The firm’s 50 day simple moving average is $202.15 and its 200-day simple moving average is $207.48. The firm has a market capitalization of $69.65 billion, a PE ratio of 22.01, a PEG ratio of 5.11 and a beta of 0.52. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.44 by $0.06. The firm had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.48 billion. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The business’s quarterly revenue was up 3.2% on a year-over-year basis. During the same quarter last year, the firm earned $2.42 EPS. As a group, analysts expect that CME Group Inc. will post 9.74 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Friday, June 7th were given a dividend of $1.15 per share. The ex-dividend date of this dividend was Friday, June 7th. This represents a $4.60 dividend on an annualized basis and a yield of 2.38%. CME Group’s dividend payout ratio is currently 52.33%.

Wall Street Analysts Forecast Growth

A number of analysts have commented on CME shares. Piper Sandler reduced their price target on CME Group from $250.00 to $235.00 and set an “overweight” rating for the company in a research report on Tuesday. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $210.00 target price (down previously from $235.00) on shares of CME Group in a research report on Friday, April 5th. Morgan Stanley increased their target price on CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research report on Tuesday, April 9th. Barclays cut their target price on CME Group from $228.00 to $208.00 and set an “equal weight” rating for the company in a research report on Wednesday. Finally, Keefe, Bruyette & Woods reiterated a “market perform” rating and set a $226.00 target price on shares of CME Group in a research report on Wednesday, July 3rd. Three research analysts have rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, CME Group presently has an average rating of “Hold” and a consensus target price of $215.82.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.